News

Novavax, Inc. announced that Nuvaxovid XBB.1.5 COVID-19 Vaccine (NVX-CoV2601) has been granted Emergency Use Listing (EUL) by the World Health Organization (WHO) for active immunization…
Read More...

Aro Biotherapeutics, a clinical stage biotechnology company pioneering the development of tissue-targeted genetic medicines, announced it has secured $41.5M in a Series B funding round.…
Read More...

AmacaThera, a leader in the development of novel injectable, localized therapeutics based upon its AmacaGel delivery platform, announced the closing of a CAD$4.0 million financing…
Read More...

PRISM BioLab, Co. Ltd. announced that it has entered into a License and Collaboration Agreement with Eli Lilly and Company ("Lilly"). Under the agreement, PRISM and Lilly will…
Read More...

Boehringer Ingelheim and IBM announced an agreement that will enable Boehringer to use IBM’s foundation model technologies to discover novel candidate antibodies for the development…
Read More...

AbbVie announced updates from the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) for epcoritamab, an investigational T-cell engaging bispecific antibody…
Read More...

Genelux Corporation announced that the United States Food and Drug Administration (FDA) has granted Fast Track designation for the development program of Olvi-Vec (olvimulogene…
Read More...

Vertex Pharmaceuticals Incorporated announced that the European Commission has granted approval for the label expansion of KAFTRIO (ivacaftor/tezacaftor/elexacaftor) in a combination…
Read More...

SK bioscience, an innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that the company has entered into a development licensing…
Read More...

Boehringer Ingelheim, a global leader in animal health, has received marketing authorization from the European Commission for SENVELGO (active ingredient: velagliflozin), marking a…
Read More...

Boehringer Ingelheim announced the acquisition of privately-held T3 Pharmaceuticals AG (“T3 Pharma”), a clinical stage Swiss biotech company, for an amount of up to 450 million CHF.…
Read More...

Vivodyne, a biotech that discovers and develops more effective drugs by testing them on lab-grown human organs, announced the close of $38 million in total seed financing, led by Khosla…
Read More...

NeoImmuneTech, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for their investigational drug NT-I7 (efineptakin alfa)…
Read More...

The Janssen Pharmaceutical Companies of Johnson & Johnson announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration…
Read More...

Merck, known as MSD outside of the United States and Canada, and Caraway Therapeutics, Inc. announced that the companies have entered into a definitive agreement under which Merck,…
Read More...

Genentech, a member of the Roche Group announced a multi-year strategic research collaboration with NVIDIA that couples Genentech’s artificial intelligence (AI) capabilities, extensive…
Read More...

Chiesi Farmaceutici S.p.A ("Chiesi Group"), an international, research-focused biopharmaceuticals and healthcare group, and Haisco Pharmaceutical Group Co.Ltd (Haisco Pharmaceutical)…
Read More...

AstraZeneca’s Truqap (capivasertib) in combination with Faslodex (fulvestrant) has been approved in the US for the treatment of adult patients with hormone receptor (HR)-positive,…
Read More...

BeiGene, Ltd. announced that the European Commission (EC) has granted marketing authorization for BRUKINSA (zanubrutinib) in combination with obinutuzumab for the treatment of adult…
Read More...

AstraZeneca launches Evinova, set to be a leading provider of digital health solutions to better meet the needs of healthcare professionals, regulators and patients. With long-term…
Read More...